Stockpiling of raw material for oseltamivir is not justifiedBMJ 2006; 332 doi: https://doi.org/10.1136/bmj.332.7534.178 (Published 19 January 2006) Cite this as: BMJ 2006;332:178
- Alberto A E Bertelli, research physician (firstname.lastname@example.org)
- Department of Human Morphology, University of Milan, via Mangiagalli 31, 20133 Milan, Italy
Editor—Mudur reports that Roche has granted a sublicence for the production of the antiviral drug oseltamivir (Tamiflu) to an Indian company and points out that the supply of raw material, shikimic acid (extracted from the Chinese spice star anise Illicium verum …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial